2325
IRUS Total
Downloads
  Altmetric

British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017

File Description SizeFormat 
BAP Perinatal guideline Submitted version.docAccepted version1.71 MBMicrosoft WordView/Open
Title: British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017
Authors: McAllister-Williams, RH
Baldwin, DS
Cantwell, R
Easter, A
Gilvarry, E
Glover, V
Green, L
Gregoire, A
Howard, LM
Jones, I
Khalifeh, H
Lingford-Hughes, A
McDonald, E
Micali, N
Pariante, CM
Peters, L
Roberts, A
Smith, NC
Taylor, D
Wieck, A
Yates, LM
Young, AH
Item Type: Journal Article
Abstract: Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.
Issue Date: 25-Apr-2017
Date of Acceptance: 1-Apr-2017
URI: http://hdl.handle.net/10044/1/48784
DOI: https://dx.doi.org/10.1177/0269881117699361
ISSN: 0269-8811
Publisher: SAGE
Start Page: 519
End Page: 552
Journal / Book Title: JOURNAL OF PSYCHOPHARMACOLOGY
Volume: 31
Issue: 5
Copyright Statement: © 2017 The Author(s). Reprints and permissions: sagepub.co.uk/journalsPermissions.nav. The final, definitive version of this paper has been published in Journal of Psychopharmacology 2017, Vol. 31(5) 519–552, DOI: 10.1177/0269881117699361 by Sage Publications Ltd. All rights reserved. It is available at: https://dx.doi.org/10.1177/0269881117699361
Sponsor/Funder: Genesis Research Trust
Funder's Grant Number: N/A
Keywords: Science & Technology
Life Sciences & Biomedicine
Clinical Neurology
Neurosciences
Pharmacology & Pharmacy
Psychiatry
Neurosciences & Neurology
Antidepressants
antipsychotics
anxiolytics
birth defects
breastfeeding
child development
conception
fertility
hypnotics
mood stabilisers
neonatal problems
postpartum
pregnancy
pregnancy outcome
psychiatric illness
psychotropics
teratogenicity
SEROTONIN-REUPTAKE INHIBITORS
POPULATION-BASED COHORT
AUTISM SPECTRUM DISORDER
IN-UTERO EXPOSURE
TRANSCRANIAL MAGNETIC STIMULATION
PERSISTENT PULMONARY-HYPERTENSION
BENZODIAZEPINE-RECEPTOR AGONISTS
PRENATAL ANTIDEPRESSANT EXPOSURE
INTRAUTERINE GROWTH-RETARDATION
DEFICIT HYPERACTIVITY DISORDER
11 Medical And Health Sciences
17 Psychology And Cognitive Sciences
Publication Status: Published
Appears in Collections:Department of Medicine (up to 2019)